Impairment of the TGF-β1 system in SLE not only may impact on the autoimmune pathophysiology of the disease but also may modulate the development of atherosclerosis and the increased risk for cardiovascular disease. This evidence concerns the gene TGFB1 and systemic lupus erythematosus.